PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence

Jesús Gonzalo-Asensio, Serge Mostowy, Jose Harders-Westerveen, Kris Huygen, Rogelio Hernández-Pando, Jelle Thole, Marcel Behr, Brigitte Gicquel, Carlos Martín, Jesús Gonzalo-Asensio, Serge Mostowy, Jose Harders-Westerveen, Kris Huygen, Rogelio Hernández-Pando, Jelle Thole, Marcel Behr, Brigitte Gicquel, Carlos Martín

Abstract

Inactivation of the transcriptional regulator PhoP results in Mycobacterium tuberculosis attenuation. Preclinical testing has shown that attenuated M. tuberculosis phoP mutants hold promise as safe and effective live vaccine candidates. We focused this study to decipher the virulence networks regulated by PhoP. A combined transcriptomic and proteomic analysis revealed that PhoP controls a variety of functions including: hypoxia response through DosR crosstalking, respiratory metabolism, secretion of the major T-cell antigen ESAT-6, stress response, synthesis of pathogenic lipids and the M. tuberculosis persistence through transcriptional regulation of the enzyme isocitrate lyase. We also demonstrate that the M. tuberculosis phoP mutant SO2 exhibits an antigenic capacity similar to that of the BCG vaccine. Finally, we provide evidence that the SO2 mutant persists better in mouse organs than BCG. Altogether, these findings indicate that PhoP orchestrates a variety of functions implicated in M. tuberculosis virulence and persistence, making phoP mutants promising vaccine candidates.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. The M. tuberculosis PhoP regulon.
Figure 1. The M. tuberculosis PhoP regulon.
The PhoP regulon was identified by comparing transcriptional profiles of the M. tuberculosis wild type and the phoP mutant using DNA microarrays. Some of the more relevant genes to virulence and intracellular survival are listed and grouped by function. Green and red arrows indicate genes whose expression is positively or negatively regulated by PhoP, respectively.
Figure 2. Protein expression patterns of M.…
Figure 2. Protein expression patterns of M. tuberculosis and the phoP mutant.
Areas of 2D-polyacrylamide gels show differences in the protein expression patterns between the wild type strain and the phoP mutant. Spots that showed at least three-fold differential expression across triplicate gels were selected for identification by mass spectrometry. EspB and Hsp65 are more expressed in the wild type strain while ICL shows a higher expression in the phoP mutant. The vertical arrows indicate decreased (↓) or increased (↑) expression in the M. tuberculosis phoP mutant relative to the parent strain.
Figure 3. Quantification of gene expression by…
Figure 3. Quantification of gene expression by qRT-PCR.
Relative expression levels of the dosR, nuoB, lipF, pks3 and icl genes. The relative quantity (RQ) for each gene in the phoP mutant and the complemented strain were calculated with respect to the gene expression levels in the wild type strain. The expression levels of each gene in each strain were normalized to the levels of sigA mRNA. Primers and probe sequences for the aforementioned genes as well as for the endogenous control sigA are listed in Table S3.
Figure 4. Schematic representation of the PhoP-regulated…
Figure 4. Schematic representation of the PhoP-regulated genes within the extRD1 region.
The extRD1 region includes genes essential for ESAT-6/CFP10 secretion (blue), genes essential for ESAT-6/CFP10 expression (green) and genes implicated in RD1-mediated virulence (red). Genes identified as positively regulated by PhoP are indicated (+).
Figure 5. Determination of sensitivity to the…
Figure 5. Determination of sensitivity to the ICL inhibitor 3-NP.
The wild type, phoP mutant and complemented strains were tested for their ability to grow in 7H9 medium supplemented with glucose or propionate as sole carbon sources in the presence of 3-NP. A change from blue to pink coloration is indicative of resazurin reduction and consequently it correlates with bacterial viability. No differences in 3-NP sensitivity were observed when the wild type, the phoP mutant or the complemented strains were grown in glucose as unique carbon source. The phoP mutant is less sensitive to 3-NP than the parental strain when grown in propionate as sole carbon supplier, indicating higher levels of ICL expression in the mutant. Complementation of the mutant with the phoPR operon renders bacteria as susceptible to 3-NP as the parental strain when propionate is the unique carbon source.
Figure 6. Hsp65- and Ag85A-specific responses exhibited…
Figure 6. Hsp65- and Ag85A-specific responses exhibited by mice immunised with M. tuberculosis phoP mutant and BCG.
Cells from spleen, lungs and lymph nodes from mice immunised with either BCG or the phoP mutant were stimulated with Hsp65 or Ag85A (p 85) and IFNγ production was measured by ELISA. Bars represent mean and SD from two separate experiments. Asterisks indicate significant differences in IFN-γ production. A higher percentage of Hsp65-specific cells is found in spleen and lymph nodes from mice immunized with SO2 when compared with BCG-immunised mice. Lymph nodes from SO2-immunised mice contained a higher fraction of cell responding to Ag85 in comparison with BCG-immunised mice.
Figure 7. Persistence of BCG and the…
Figure 7. Persistence of BCG and the M. tuberculosis phoP mutant in BALB/c mice.
Animals were intravenously infected with either BCG or the SO2 phoP mutant. Bars represent mean and SD of log10 CFUs recovered from spleen and lungs of inoculated animal at 1 and 3 months after the initial infection. Asterisks indicate significant differences in CFU counts. We were unable to compare persistence of the SO2 phoP mutant with the wild type since the latter strain kills animals by day 60 post infection (data not shown).

References

    1. Rohde K, Yates RM, Purdy GE, Russell DG. Mycobacterium tuberculosis and the environment within the phagosome. Immunol Rev. 2007;219:37–54.
    1. Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu Rev Microbiol. 2001;55:139–163.
    1. Boshoff HI, Barry CE., 3rd Tuberculosis - metabolism and respiration in the absence of growth. Nat Rev Microbiol. 2005;3:70–80.
    1. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, et al. Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment. J Exp Med. 2003;198:693–704.
    1. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, et al. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin. Proc Natl Acad Sci U S A. 2001;98:7534–7539.
    1. Voskuil MI, Visconti KC, Schoolnik GK. Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy. Tuberculosis (Edinb) 2004;84:218–227.
    1. Rustad TR, Harrell MI, Liao R, Sherman DR. The enduring hypoxic response of Mycobacterium tuberculosis. PLoS ONE. 2008;3:e1502.
    1. Rohde KH, Abramovitch RB, Russell DG. Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues. Cell Host Microbe. 2007;2:352–364.
    1. Fontan P, Aris V, Ghanny S, Soteropoulos P, Smith I. Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect Immun. 2008;76:717–725.
    1. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, et al. Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages. PLoS ONE. 2008;3:e1403.
    1. Perez E, Samper S, Bordas Y, Guilhot C, Gicquel B, et al. An essential role for phoP in Mycobacterium tuberculosis virulence. Mol Microbiol. 2001;41:179–187.
    1. Martin C, Williams A, Hernandez-Pando R, Cardona PJ, Gormley E, et al. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs. Vaccine. 2006;24:3408–3419.
    1. Chesne-Seck ML, Barilone N, Boudou F, Gonzalo Asensio J, Kolattukudy PE, et al. A point mutation in the two-component regulator PhoP-PhoR accounts for the absence of polyketide-derived acyltrehaloses but not that of phthiocerol dimycocerosates in Mycobacterium tuberculosis H37Ra. J Bacteriol. 2008;190:1329–1334.
    1. Frigui W, Bottai D, Majlessi L, Monot M, Josselin E, et al. Control of M. tuberculosis ESAT-6 Secretion and Specific T Cell Recognition by PhoP. PLoS Pathog. 2008;4:e33.
    1. Lee JS, Krause R, Schreiber J, Mollenkopf HJ, Kowall J, et al. Mutation in the transcriptional regulator PhoP contributes to avirulence of Mycobacterium tuberculosis H37Ra strain. Cell Host Microbe. 2008;3:97–103.
    1. Gonzalo Asensio J, Maia C, Ferrer NL, Barilone N, Laval F, et al. The virulence-associated two-component PhoP-PhoR system controls the biosynthesis of polyketide-derived lipids in Mycobacterium tuberculosis. J Biol Chem. 2006;281:1313–1316.
    1. Gonzalo-Asensio J, Soto CY, Arbues A, Sancho J, Menendez MD, et al. Mycobacterium tuberculosis phoPR operon is positively autoregulated in the virulent strain H37Rv. J Bacteriol 2008
    1. Voskuil MI, Schnappinger D, Visconti KC, Harrell MI, Dolganov GM, et al. Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program. J Exp Med. 2003;198:705–713.
    1. Park HD, Guinn KM, Harrell MI, Liao R, Voskuil MI, et al. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis. Mol Microbiol. 2003;48:833–843.
    1. Kumar A, Toledo JC, Patel RP, Lancaster JR, Jr, Steyn AJ. Mycobacterium tuberculosis DosS is a redox sensor and DosT is a hypoxia sensor. Proc Natl Acad Sci U S A. 2007;104:11568–11573.
    1. Shiloh MU, Manzanillo P, Cox JS. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe. 2008;3:323–330.
    1. Kinger AK, Tyagi JS. Identification and cloning of genes differentially expressed in the virulent strain of Mycobacterium tuberculosis. Gene. 1993;131:113–117.
    1. Dasgupta N, Kapur V, Singh KK, Das TK, Sachdeva S, et al. Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. Tuber Lung Dis. 2000;80:141–159.
    1. Waddell SJ, Butcher PD. Microarray analysis of whole genome expression of intracellular Mycobacterium tuberculosis. Curr Mol Med. 2007;7:287–296.
    1. Velmurugan K, Chen B, Miller JL, Azogue S, Gurses S, et al. Mycobacterium tuberculosis nuoG Is a Virulence Gene That Inhibits Apoptosis of Infected Host Cells. PLoS Pathog. 2007;3:e110.
    1. Winau F, Hegasy G, Kaufmann SH, Schaible UE. No life without death–apoptosis as prerequisite for T cell activation. Apoptosis. 2005;10:707–715.
    1. Hutter B, Dick T. Increased alanine dehydrogenase activity during dormancy in Mycobacterium smegmatis. FEMS Microbiol Lett. 1998;167:7–11.
    1. Wayne LG, Hayes LG. Nitrate reduction as a marker for hypoxic shiftdown of Mycobacterium tuberculosis. Tuber Lung Dis. 1998;79:127–132.
    1. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol. 2002;46:709–717.
    1. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science. 1999;284:1520–1523.
    1. Brodin P, Majlessi L, Marsollier L, de Jonge MI, Bottai D, et al. Dissection of ESAT-6 system 1 of Mycobacterium tuberculosis and impact on immunogenicity and virulence. Infect Immun. 2006;74:88–98.
    1. Guinn KM, Hickey MJ, Mathur SK, Zakel KL, Grotzke JE, et al. Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol. 2004;51:359–370.
    1. Stanley SA, Raghavan S, Hwang WW, Cox JS. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system. Proc Natl Acad Sci U S A. 2003;100:13001–13006.
    1. McLaughlin B, Chon JS, MacGurn JA, Carlsson F, Cheng TL, et al. A Mycobacterium ESX-1-secreted virulence factor with unique requirements for export. PLoS Pathog. 2007;3:e105.
    1. Xu J, Laine O, Masciocchi M, Manoranjan J, Smith J, et al. A unique Mycobacterium ESX-1 protein co-secretes with CFP-10/ESAT-6 and is necessary for inhibiting phagosome maturation. Mol Microbiol. 2007;66:787–800.
    1. Raghavan S, Manzanillo P, Chan K, Dovey C, Cox JS. Secreted transcription factor controls Mycobacterium tuberculosis virulence. Nature. 2008;454:717–721.
    1. Walters SB, Dubnau E, Kolesnikova I, Laval F, Daffe M, et al. The Mycobacterium tuberculosis PhoPR two-component system regulates genes essential for virulence and complex lipid biosynthesis. Mol Microbiol. 2006;60:312–330.
    1. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol. 1999;34:257–267.
    1. Gao Q, Kripke K, Arinc Z, Voskuil M, Small P. Comparative expression studies of a complex phenotype: cord formation in Mycobacterium tuberculosis. Tuberculosis (Edinb) 2004;84:188–196.
    1. Munoz-Elias EJ, Upton AM, Cherian J, McKinney JD. Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence. Mol Microbiol. 2006;60:1109–1122.
    1. Upton AM, McKinney JD. Role of the methylcitrate cycle in propionate metabolism and detoxification in Mycobacterium smegmatis. Microbiology. 2007;153:3973–3982.
    1. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, et al. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature. 2000;406:735–738.
    1. Sharma V, Sharma S, Hoener zu Bentrup K, McKinney JD, Russell DG, et al. Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis. Nat Struct Biol. 2000;7:663–668.
    1. Skeiky YA, Sadoff JC. Advances in tuberculosis vaccine strategies. Nat Rev Microbiol. 2006;4:469–476.
    1. Roberts DM, Liao RP, Wisedchaisri G, Hol WG, Sherman DR. Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis. J Biol Chem. 2004;279:23082–23087.
    1. Roupie V, Romano M, Zhang L, Korf H, Lin MY, et al. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun. 2007;75:941–949.
    1. Honaker RW, Stewart A, Schittone S, Izzo A, Klein MR, et al. BCG vaccine strains lack narK2 and narX induction and exhibit altered phenotypes during dormancy. Infect Immun 2008
    1. Reed MB, Gagneux S, Deriemer K, Small PM, Barry CE., 3rd The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol. 2007;189:2583–2589.
    1. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol. 2002;43:717–731.
    1. Chan K, Knaak T, Satkamp L, Humbert O, Falkow S, et al. Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc Natl Acad Sci U S A. 2002;99:3920–3925.
    1. Rosenkrands I, Slayden RA, Crawford J, Aagaard C, Barry CE, 3rd, et al. Hypoxic response of Mycobacterium tuberculosis studied by metabolic labeling and proteome analysis of cellular and extracellular proteins. J Bacteriol. 2002;184:3485–3491.
    1. Chen JM, Alexander DC, Behr MA, Liu J. Mycobacterium bovis BCG vaccines exhibit defects in alanine and serine catabolism. Infect Immun. 2003;71:708–716.
    1. Dubnau E, Fontan P, Manganelli R, Soares-Appel S, Smith I. Mycobacterium tuberculosis genes induced during infection of human macrophages. Infect Immun. 2002;70:2787–2795.
    1. Senaratne RH, De Silva AD, Williams SJ, Mougous JD, Reader JR, et al. 5′-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. Mol Microbiol. 2006;59:1744–1753.
    1. Senaratne RH, Mougous JD, Reader JR, Williams SJ, Zhang T, et al. Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant. J Med Microbiol. 2007;56:454–458.
    1. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis. 2003;187:117–123.
    1. Hsu T, Hingley-Wilson SM, Chen B, Chen M, Dai AZ, et al. The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue. Proc Natl Acad Sci U S A. 2003;100:12420–12425.
    1. Gao LY, Guo S, McLaughlin B, Morisaki H, Engel JN, et al. A mycobacterial virulence gene cluster extending RD1 is required for cytolysis, bacterial spreading and ESAT-6 secretion. Mol Microbiol. 2004;53:1677–1693.
    1. Mattow J, Jungblut PR, Schaible UE, Mollenkopf HJ, Lamer S, et al. Identification of proteins from Mycobacterium tuberculosis missing in attenuated Mycobacterium bovis BCG strains. Electrophoresis. 2001;22:2936–2946.
    1. Hobson RJ, McBride AJ, Kempsell KE, Dale JW. Use of an arrayed promoter-probe library for the identification of macrophage-regulated genes in Mycobacterium tuberculosis. Microbiology. 2002;148:1571–1579.
    1. Stewart GR, Wernisch L, Stabler R, Mangan JA, Hinds J, et al. Dissection of the heat-shock response in Mycobacterium tuberculosis using mutants and microarrays. Microbiology. 2002;148:3129–3138.
    1. Graham JE, Clark-Curtiss JE. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U S A. 1999;96:11554–11559.
    1. Munoz-Elias EJ, McKinney JD. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat Med. 2005;11:638–644.
    1. Asensio JA, Arbues A, Perez E, Gicquel B, Martin C. Live tuberculosis vaccines based on phoP mutants: a step towards clinical trials. Expert Opin Biol Ther. 2008;8:201–211.
    1. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 1998;393:537–544.

Source: PubMed

3
Suscribir